A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)
A Phase 2, Multicenter, Randomized, Proof-of-Concept, Double-Blind, Placebo-Controlled, Parallel-Group Study, Including an Open-Label Period, Evaluating the Efficacy and Safety of 1 Subcutaneous Dose Regimen of Fremanezumab for the Treatment of Posttraumatic Headache (PTH)
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
A PHASE2 clinical study on Post-Traumatic Headache, this trial is completed. The trial is conducted by Teva Branded Pharmaceutical Products R&D, Inc. and has accumulated 26 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
26 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2021 — Jan 2023 [monthly]
Completed PHASE2
▶ Show 21 earlier versions
-
May 2021 — Dec 2021 [monthly]
Completed PHASE2
-
Apr 2021 — May 2021 [monthly]
Completed PHASE2
-
Jan 2021 — Apr 2021 [monthly]
Completed PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Completed PHASE2
-
Aug 2020 — Sep 2020 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE2
-
May 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2020 — May 2020 [monthly]
Recruiting PHASE2
-
Nov 2019 — Jan 2020 [monthly]
Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE2
-
Jul 2019 — Sep 2019 [monthly]
Recruiting PHASE2
-
May 2019 — Jul 2019 [monthly]
Recruiting PHASE2
-
Mar 2019 — May 2019 [monthly]
Recruiting PHASE2
-
Jan 2019 — Mar 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Jan 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Teva Branded Pharmaceutical Products R&D, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .